26-Hydroxycholesterol

26-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 26-hydroxycholesterol is associated with abnormalities such as Cardiovascular Diseases, Vascular Diseases, Metabolic syndrome, Obesity and Fatty Streak, Arterial. The involved functions are known as Oxidation, phospholipase activity, glucose metabolism, Binding (Molecular Function) and Regulation. 26-hydroxycholesterol often locates in Immune system, Body tissue, Extracellular, Protoplasm and Back. The associated genes with 26-Hydroxycholesterol are Homologous Gene, chylomicron remnant, Receptor Gene, Alleles and D3 compound. The related lipids are 27-hydroxycholesterol, Hydroxycholesterols, Lysophosphatidylcholines, Total cholesterol and Lipopolysaccharides. The related experimental models are Knock-out and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of 26-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 26-Hydroxycholesterol?

26-Hydroxycholesterol is suspected in hypercholesterolemia, Obesity, Atherosclerosis, Metabolic syndrome, Neurodegenerative Disorders, Dyslipidemias and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 26-Hydroxycholesterol

MeSH term MeSH ID Detail
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Alcoholism D000437 27 associated lipids
Alzheimer Disease D000544 76 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Inflammation D007249 119 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 26-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 26-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 26-Hydroxycholesterol?

Transgenic Model

Transgenic Model are used in the study 'Cholesterol and breast cancer pathophysiology.' (Nelson ER et al., 2014) and Transgenic Model are used in the study 'Obesity, cholesterol metabolism, and breast cancer pathogenesis.' (McDonnell DP et al., 2014).

Knock-out

Knock-out are used in the study 'The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.' (Umetani M et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 26-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 403
Authors Title Published Journal PubMed Link
Iborra RT et al. Advanced glycation in macrophages induces intracellular accumulation of 7-ketocholesterol and total sterols by decreasing the expression of ABCA-1 and ABCG-1. 2011 Lipids Health Dis pmid:21957962
Zhou Q and Kummerow FA Modifying effect of 26-hydroxycholesterol on low-magnesium-induced atherosclerotic changes in the cultured human arterial smooth muscle cell. 1993 Magnes Res pmid:8274357
He S and Nelson ER 27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator. 2017 Maturitas pmid:28923174
Raza S et al. 27-Hydroxycholesterol stimulates cell proliferation and resistance to docetaxel-induced apoptosis in prostate epithelial cells. 2016 Med. Oncol. pmid:26732475
Honda A et al. Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits. 2004 Metab. Clin. Exp. pmid:14681840
Nelson ER Detection of Endogenous Selective Estrogen Receptor Modulators such as 27-Hydroxycholesterol. 2016 Methods Mol. Biol. pmid:26585155
Mathieu JM et al. Medical bioremediation of age-related diseases. 2009 Microb. Cell Fact. pmid:19358742
Wang Y et al. Targeted lipidomic analysis of oxysterols in the embryonic central nervous system. 2009 Mol Biosyst pmid:19381367
Prasanthi JR et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. 2009 Mol Neurodegener pmid:19126211
Marwarha G et al. Molecular interplay between leptin, insulin-like growth factor-1, and β-amyloid in organotypic slices from rabbit hippocampus. 2011 Mol Neurodegener pmid:21651786
Akram A et al. Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis? 2010 Mol Neurodegener pmid:20843353
Fu H et al. β-Cryptoxanthin uptake in THP-1 macrophages upregulates the CYP27A1 signaling pathway. 2014 Mol Nutr Food Res pmid:24123714
Olkkonen VM and Hynynen R Interactions of oxysterols with membranes and proteins. 2009 Mol. Aspects Med. pmid:19248802
Björkhem I et al. Oxysterols and neurodegenerative diseases. 2009 Mol. Aspects Med. pmid:19248803
Raza S et al. The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells. 2015 Mol. Cell. Biochem. pmid:26350565
Szanto A et al. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. 2004 Mol. Cell. Biol. pmid:15340076
Ullrich C et al. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. 2010 Mol. Cell. Neurosci. pmid:20696249
DuSell CD et al. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. 2008 Mol. Endocrinol. pmid:17872378
Berrodin TJ et al. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity. 2010 Mol. Pharmacol. pmid:20837678
van de Kraats C et al. Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis. 2014 Mult. Scler. pmid:23959711
Warner M and Gustafsson JA On estrogen, cholesterol metabolism, and breast cancer. 2014 N. Engl. J. Med. pmid:24499217
Nguyen VT et al. Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion. 2015 Nat Commun pmid:26610607
Baek AE et al. The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. 2017 Nat Commun pmid:29021522
Greenhill C Bone: High 27-hydroxycholesterol decreases BMD. 2010 Nat Rev Endocrinol pmid:20803803
Umetani M et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. 2007 Nat. Med. pmid:17873880
Koschack J et al. Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals. 2009 Neurobiol. Aging pmid:18061309
Teunissen CE et al. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. 2003 Jan-Feb Neurobiol. Aging pmid:12493560
van den Kommer TN et al. Total cholesterol and oxysterols: early markers for cognitive decline in elderly? 2009 Neurobiol. Aging pmid:17888546
Sharma S et al. Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. 2008 Neurobiol. Dis. pmid:18775495
Milagre I et al. Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells. 2012 Neurochem. Int. pmid:22185844
Ma WW et al. The oxysterol 27-hydroxycholesterol increases oxidative stress and regulate Nrf2 signaling pathway in astrocyte cells. 2015 Neurochem. Res. pmid:25630716
Mateos L et al. side-chain-oxidized oxysterols upregulate ACE2 and Mas receptor in rat primary neurons. 2012 Neurodegener Dis pmid:22236548
Cheng D et al. Regulation of alpha-synuclein expression by liver X receptor ligands in vitro. 2008 Neuroreport pmid:18841091
Holdenrieder S et al. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke? 2004 Neurosci. Lett. pmid:15351449
Kölsch H et al. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. 2004 Neurosci. Lett. pmid:15364416
Solomon A et al. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. 2009 Neurosci. Lett. pmid:19560513
Emanuelsson I and Norlin M Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells. 2012 Neurosci. Lett. pmid:22884615
Leoni V et al. Whole body cholesterol metabolism is impaired in Huntington's disease. 2011 Neurosci. Lett. pmid:21406216
Björkhem I et al. Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. 2013 Neurosci. Lett. pmid:24035896
Holzapfel J et al. PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease. 2006 Neurosci. Lett. pmid:16979821
Wang H et al. The cytotoxicity of 27-hydroxycholesterol in co-cultured SH-SY5Y cells and C6 cells. 2016 Neurosci. Lett. pmid:27592060
Zhang DD et al. 27-Hydroxycholesterol contributes to disruptive effects on learning and memory by modulating cholesterol metabolism in the rat brain. 2015 Neuroscience pmid:25987203
Gilardi F et al. Expression of sterol 27-hydroxylase in glial cells and its regulation by liver X receptor signaling. 2009 Neuroscience pmid:19665519
Jenner AM et al. The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice. 2010 Neuroscience pmid:20416362
An Y et al. 27-Hydroxycholesterol regulates cholesterol synthesis and transport in C6 glioma cells. 2017 Neurotoxicology pmid:28167099
Zhou C et al. The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. 2009 Nucl Recept Signal pmid:19240808
Bertolotti M et al. Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: a possible compensatory mechanism. 2012 Nutr Metab Cardiovasc Dis pmid:21546230
Torres CG et al. 27-hydroxycholesterol induces the transition of MCF7 cells into a mesenchymal phenotype. 2011 Oncol. Rep. pmid:21567091
Cruz P et al. 27-hydroxycholesterol and the expression of three estrogen-sensitive proteins in MCF7 cells. 2012 Oncol. Rep. pmid:22710948
Kumari U and Heese K Cardiovascular dementia - a different perspective. 2010 Open Biochem J pmid:20448820